Rebound and Resistance in Targeted Therapies

December 24th, 2014 by Bryan Lewis

John Ebos of Roswell Park Cancer Institute was granted a Career Development Award by the Congressionally Directed Medical Research Programs of the Department of Defense (DoD) to study, using a pre-clinical model, rebound and resistance to targeted therapies in RCC. This two-year grant was funded at $602,996 in Fiscal Year 2013 (the latest award year)…. More →

Read More

Launching New Website

December 7th, 2014 by Jay Bitkower

Today ACKC is launching its new website, updating older material and adding new content, which we will continue to do in the future. Two new features on the Homepage are “News” and “Point of View” essays. News will commence with two articles, one highlighting two studies on the use of sunitinib (Sutent) in the elderly,… More →

Read More

ACKC’s Advocacy Campaign Pays Off!

December 6th, 2014 by Sara Mears

Maria Czyzyk-Krzeska of the University of Cincinnati received a two-year, IDEA grant of $474,562 from the Department of Defense to work on the effects of tobacco smoke on growth of clear cell renal cell carcinoma (ccRCC). Smoking is the major risk factor in getting kidney cancer, but the genetic signaling in RCC that is caused… More →

Read More

A recent original study reported in Clinical Genitourinary Cancer ®, June, 2014, Vol. 12, No.3 provides a ray of hope for elderly patients with metastatic RCC. Led by Dr. Ugo De Giorgi and a team of Italian oncologists, a retrospective study of 185 patients revealed that an alternative regimen of up to half the standard… More →

Read More


December 3rd, 2014 by Sara Mears

jggiugiugiugiu uyuyuyfyufuy

Read More